Cholesterol-Lowering Drugs Market

Cholesterol-Lowering Drugs Market contains market size and forecasts of Cholesterol-Lowering Drugs in global, including the following market information:

• Global Cholesterol-Lowering Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cholesterol-Lowering Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Cholesterol-Lowering Drugs companies in 2021 (%)

The global Cholesterol-Lowering Drugs market was valued at 17940 million in 2021 and is projected to reach US$ 21560 million by 2028, at a CAGR of 2.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Statins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cholesterol-Lowering Drugs include AstraZeneca, Merck, Pfizer, Kowa, Daiichi Sankyo, AbbVie, Novartis, Sanofi and Amgen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cholesterol-Lowering Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cholesterol-Lowering Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Cholesterol-Lowering Drugs Market Segment Percentages, by Type, 2021 (%)

• Statins
• Cholesterol Absorption Inhibitors
• Fibrates
• PCSK9 Inhibitors

Global Cholesterol-Lowering Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Cholesterol-Lowering Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Household
• Other

Global Cholesterol-Lowering Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Cholesterol-Lowering Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cholesterol-Lowering Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cholesterol-Lowering Drugs revenues share in global market, 2021 (%)
• Key companies Cholesterol-Lowering Drugs sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Cholesterol-Lowering Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Merck
• Pfizer
• Kowa
• Daiichi Sankyo
• AbbVie
• Novartis
• Sanofi
• Amgen
• Bristol-Myers Squibb